when was the vaccine released to the public

More than $3 billion of the sum will be made available through the CDC Immunization and Vaccines for Children cooperative agreement. Some sources suggest these practices were taking place as early as 200 BCE. RSV Vaccines: What to Know For Babies, Pregnant Women and Older Adults Following reports of 15 million J&J vaccine doses spoiled at a Baltimore plant, federal regulators have now found more flaws at the facility. Vermont has the highest vaccination rate at 74.5% while Mississippi had the lowest rate with just 41.5% of its population receiving at least 1 dose. The company issues a statement saying there is no scientific evidence for the association despite countries halting use of the vaccine. A study in the New England Journal of Medicine unveils the cause behind abnormal, rare clotting events associated with the COVID-19 vaccine manufactured by AstraZeneca and the University of Oxford, finding that antibodies for clot-promoting platelet factor 4 (PF4) on enzyme-linked immunosorbent assay (ELISA) were present in 5 of the 7 patients who developed blood clots. The move comes amid reports that its approved vaccine was less potent against the variant identified in South Africa. Following its decision not to renew a COVID-19 vaccine contract with Johnson & Johnson and AstraZeneca, the European Union announces it will extend its contact with Pfizer/BioNTech. Indoors, masking is still recommended for both vaccinated and unvaccinated individuals. Biden Says Vaccines Will Be Available for Every US Adult by May. The companies will produce 100 million additional doses of GlaxoSmithKlines COVID-19 vaccine, which is in a phase 2 trial, plus they will work together to produce a new vaccine to target variants of the virus. As global COVID-19 vaccine inequities continue to mount, the United States will donate the majority of its unused vaccines to nations in the WHO's Covax program, the Associated Press reports. Vaccine distribution to states additionally increased from 8.6 million to 10 million, a 16% bump in doses. The revelation came shortly after the former president recommended in a speech for his followers to get vaccinated. The 2-shot Novavax vaccine had 89% efficacy in a United Kingdom trial. This news comes asthe White House announcedthat President Bidens goal of 70% of adults having at least 1 COVID-19 vaccine dose by July 4 will not be met. With research into hundreds of vaccine candidates, there are now 3 vaccines approved by the FDA. The vaccine is not yet approved in the United States. 1400s to 1700s From at least the 15th century, people in different parts of the world have attempted to prevent illness by intentionally exposing healthy people to smallpox - a practice known as variolation (after a name for smallpox, 'la variole'). Heart Problem Investigated in Vaccinated Teens. FDA amends EUAs of Moderna and Pfizer-BioNTech COVID-19 bivalent mRNA vaccines. The variant is more contagious and reinfects people who have recovered from other versions of the virus. Following news of the global coronavirus death toll topping 3 million worldwide, nearly 130 million people 18 and older have received a vaccine dose nationwide, with the US vaccination rate standing at 61.6 doses per 100 people. The US government is paying Merck about $356 million to fast-track production of the potential treatment. Flu Vaccination May Offer Some Protection Against COVID-19. The study will also seek to optimize vaccine combination treatments if results show booster shots are warranted. 6 Million Vaccine Doses Stalled by Winter Weather. 100 Million More Doses of J&J Vaccine Ordered. Amid growing concerns of vaccine inequity worldwide, the Biden administration appointed Gayle Smith, a former director of the US Agency for International Development, to serve as the new coordinator for its global coronavirus response. The president is expected to announce a new vaccination goal next week. FDA Recommends Expedited Trials for COVID-19 Booster Shots. European Medicines Agency: AstraZeneca Vaccine is Safe. A batch of J&J COVID-19 vaccines being produced at a Baltimore plant run by Emergent BioSolutions was ruined after workers mixed up the vaccines ingredients with another that was being produced at the plant. COVID Vaccine DPH COVID-19 Guidance X Vital Records . States See Drops in Demand for COVID-19 Vaccines. The study, which used evidence from Israel 2 months into one of the fastest vaccine rollouts worldwide, also found that a single shot was 57% effective in protecting against symptomatic infections 2 weeks after vaccination. The data will be made publicly available on CMSs COVID-19 Nursing Home Data website. J&J says it would resume rollout of its COVID-19 vaccine among the 27 member states of the European Union in light of a nonbinding recommendation from the European Medicines Agency, which included adding a warning about the possibly associated rare blood clots. Vaccine Acceptance Among Americans Increases. Notably, the efficacy of both vaccines is lessened against the highly transmissible B.1.351 variant from South Africa. The United States agreed to back a proposal that temporarily waives intellectual property rights for COVID-19 vaccines to help increase the global supply. All adults will be eligible to receive a COVID-19 vaccine in Texas beginning Monday, March 29. Results also suggest just the first dose of the vaccine was 80% effective at doing so 2 weeks after administration. Former coronavirus testing czar Adm Brett Giroir encourages Trump and former Vice President Mike Pence to tell supporters to get vaccinated. When the FDA granted the EUA to J&J, the supply of doses was limited. More Americans Vaccinated Than Infected With COVID-19. Instead, it has . Polls Show Split by Party Line Over Vaccine Uptake. The human papillomavirus (HPV) vaccine is the first and only vaccination that helps protect individuals from getting many different types of cancer that are associated . Adm Brett Giroir Urges Trump to Encourage Followers to Get Vaccinated. Of those who reported incidents, 20 fully recovered while most had a history of such reactions. The company releases data from a US clinical trial highlighting the vaccines efficacy and reporting no safety concerns. FDA issues a statement cautioning health care workers against making changes to authorized dosing schedules for approved COVID-19 vaccines. Two years on, few colleges still require COVID vaccines Biden also says the possibility of returning to a semblance of normal life could be achieved by Independence Day if Americans continue to practice mitigation efforts like mask wearing and social distancing. Once COVID-19 vaccine candidates receive emergency-use authorization from the FDA, rollout is expected to begin as soon as 24 hours later. Moderna to Produce 600 Million Vaccine Doses. People who have received both doses of the 2-shot vaccines or are 2 weeks out from the single dose of the J&J vaccine may resume some activities in private, according to guidance from the CDC. 50 million doses of COVID-19 vaccines administered, at the American Thoracic Societys 2021 virtual conference. August 9, 2023 / 9:17 AM / CBS News. GlaxoSmithKline to Partner With CureVac to Accelerate COVID-19 Vaccine Production. Results of 2 studies on immune responses to the Oxford/AstraZeneca vaccine among individuals with HIV show the vaccine produced similar responses regardless of HIV status. That means all the Pfizer vaccine data should be public by the end of . An FDA advisory panel unanimously votes to move the J&J COVID-19 vaccine forward, bringing it 1 step closer to an EUA. Wait what? FDA wants 55 years to process FOIA request over vaccine data Moderna is testing doses among 12- to 18-year-olds, Pfizer is said to have recruited 12- to 15-year-olds, and AstraZeneca and Oxford University report wanting to compare outcomes among 6- to 11-year-olds and 12- to 18-year-olds. The news comes on the heels of the announcement the United States has fully vaccinated more than half of its adult population. Vaccinations Lag Among Medicaid Beneficiaries. Breakthrough infections can still occur in fully vaccinated individuals, as vaccines are not 100% effective. Given the intense public interest in the vaccine, the plaintiffs' lawyers say that the FDA "should have been preparing to release (the data) simultaneously with the licensure. Proof of Concept. Bivalent vaccines are to be used for all doses given to individuals 6 months of age and older. In its second meeting on the matter, members of the CDCs Advisory Committee on Immunization Practices (ACIP) voted to reinstate the original emergency use authorization of J&Js COVID-19 vaccine in the United States following a pause in administration implemented on April 13. In those over the age of 80, 1 dose provided 57% efficacy at preventing symptomatic COVID-19 after 3 to 4 weeks. Top reasons for these disparities, including among health care workers, are lack of access (ie, to technology and vaccines) and mistrust of the vaccine. Findings from the analysis were derived from de-identified aggregate Israel MoH surveillance data collected between January 17 and March 6, 2021, when the Pfizer-BioNTech COVID-19 Vaccine was the only vaccine available in the country and when the more transmissible B.1.1.7 variant of SARS-CoV-2 (formerly referred to as the U.K. variant) was the . The first. NEW BRUNSWICK, N.J., February 27, 2021 - Johnson & Johnson (NYSE: JNJ) (the Company) today announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for its single-dose COVID-19 vaccine, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson, to prevent COVID-19 in individuals 18 . Bidens plan does not involve cutting 2-dose vaccines in half but accelerating shipments of first doses instead of holding second doses in reserve. Accelerated expanded eligibility is also hindering recruitment of new trial enrollees. FDA Advises Against Altering Vaccine Schedules. Further trial analyses are ongoing, and data will be submitted to peer-reviewed journals for publication. The new data is based on results from a study of over 3700 participants and efficacy was shown to be 100%, following no reports of symptomatic COVID-19 in the two-thirds of participants who received both doses. As Sanofis expected delivery date of its COVID-19 vaccine was delayed to summer 2021, the company granted BioNTech access to a Frankfurt, Germany, plant in order to boost the European Union supply of its COVID-19 vaccine by more than 125 million doses. EMA Gives Go-Ahead for J&J to Resume Vaccination. The United Kingdom begins to inoculate its population with the COVID-19 vaccine manufactured by Oxford University and AstraZeneca, which can be stored at refrigerator temperatures between 2 and 8 Celsius, potentially enabling easier distribution. Among those polled, the rate of vaccination or intention to get vaccinated grew by 14 percentage points. 1961 Dr. Albert B. Sabin develops a second polio vaccine that is licensed in the U.S. A third polio vaccine will be licensed in 1963. A study from Israel shows that the first dose of the Pfizer/BioNTech vaccine is 85% effective 15 to 28 days after it is given, according to real-world data from Sheba Medical center. The plan would release $2 billion first, followed by another $2 billion over 2 years. Official Vaccine Releases: View All by Date 2023 CDC, HHS Update Vaccine Allocation Guidance. Flu Vaccine Supply for the 2023-2024 Season. Pfizer/BioNTech First Dose Effective in Real-World Data. The FDA grants an EUA to J&J for distribution of the nations third COVID-19 vaccine. These vaccines help control the spread of polio in industrialized countries. Vaccine Doses Expected to Reach 700 Million by Summer. Denmark, Norway, Iceland Suspend Use of AstraZeneca Vaccine. A Brief History of Vaccination - World Health Organization (WHO) US Data Safety Monitoring Board Questions AstraZeneca Data. Fauci: Pediatric Vaccine Rollout Likely to Begin in Early 2022. Moderna's COVID-19 vaccine is being distributed in the US this week A second vaccine has joined the fight against the coronavirus in the US. Data Show Pfizer/BioNTech Vaccine Effective After 6 Months. Data from the Kaiser Family Foundation (KFF) show a consistent pattern across states of Black and Hispanic individuals receiving smaller shares of vaccinations compared with proportions of cases and deaths in these communities and their proportion of the total population. Just 2 days after receiving the EUA, J&J announces that the first batch of its vaccine would be sent to states and pharmacies to distribute to the public. The study consisted of 29,960 adults across 113 sites. Currently, the United States has 7 million doses ready to distribute and the plan is not expected to impact the presidents mission to make vaccines available to all US adults by May. For a full look at how the pandemic evolved throughout 2020, see our timeline from last year. In the last 2 weeks, COVID-19 cases have significantly declined in more than half of US states. According to the KFF COVID-19 Vaccine Monitor, 55% of US adults say that they had either already received at least 1 dose of the vaccine or that they would get vaccinated once it became available (18% and 37%, respectively). Experts agree that without a high burden of proof, suspensions may drive future outbreaks across Europe. The letter highlights 64 disparate plans being implemented, lack of standardized tasks needed to accomplish delivery, and a failure to provide progress reports compared with plan goals. Nearly Half of Republican Men Will Not Get COVID-19 Vaccines. The United States reports it has administered 100 million COVID-19 shots, more than a month before Bidens target date of his 100th day in office, the Associated Press reports. COVID-19 vaccine: How was it developed so fast? - Medical News Today At this point, the company has supplied the US government with 18 million doses and projects to make nearly 100 million doses available to Americans by the end of the first quarter of 2021. Covid-19: First vaccine given in US as roll-out begins - BBC One of the treatments, MK-7110, has the potential to minimize the effects of an overactive immune response to COVID-19. Texas to Open COVID-19 Vaccination to All Adults on March 29 Some Adverse Reactions to J&J Vaccine Related to Anxiety. Updated guidance from the Equal Employment Opportunity Commission permits employers to mandate the COVID-19 vaccine among their workforce. FDA Approval - 4/18/23. Evidence Underscores Need to Vaccinate Those With Compromised Immune Systems. Patients vaccinated against influenza who did test positive for COVID-19 were more likely to have better clinical outcomes. Should the trial yield positive results, regulators could approve the vaccine for use in the last 3 months of 2021. Germany, Portugal, Slovenia, France, Spain, Italy, Ireland, and the Netherlands join other European nations in suspending use of the vaccine over blood clot concerns, CNBC reports. Efficacy of AstraZeneca, Pfizer Vaccines Against Variant First Identified in Brazil. The move follows discussions among allergy and immunology specialists, the CDC, the FDA, Moderna, and the County of San Diego Department of Public Health. Officials continue to sound the call for more mass vaccination sites and supportive infrastructure. AstraZeneca had previously said it would aim to provide 100 million doses by the end of June, falling short of the 300 million number specified in the contract. The study also found people with vitamin D deficiency had a lower mortality rate from Clostridioides difficile infection (CDI). As a result of a highly transmissible variant of COVID-19 spreading throughout the United Kingdom, Prime Minister Boris Johnson hints at upcoming tighter restrictions. The FDA approved storing Pfizer/BioNTechs COVID-19 vaccine in standard freezer temperatures for up to 2 weeks rather than the previously required 112 F to 76 F to help ease delivery and storage, according to The Hill. Biden is set to announce his administration will purchase 500 million doses of Pfizers COVID-19 vaccine to be donated to the rest of the world, The Washington Post reports. Polls also indicate higher levels of vaccine hesitancy among lower-income individuals. The vaccines were held up and not distributed, as it was revealed in a House subcommittee testimony the plant housed unsanitary conditions including mold and peeling paint. The drop comes as federal health officials suggest the virus trajectory is improving in the country, although uneven distribution of vaccinations remains a challenge in persuading some Americans to get vaccinated. The CDC is investigating rare cases of possible myocarditis reported in teenagers and young adults after they received a COVID-19 vaccination. Most of the wealthy residents aged 65 and older living in a gated community of the Florida Keys were inoculated against COVID-19 by mid-January while many of the states eldest residents continue to struggle to get their first dose. Reports emerge about the distribution of fake Pfizer COVID-19 vaccines in Mexico and Poland; the incidents are attributed to criminal activity. English and Scottish data show 1 dose of the Pfizer vaccine appears to slash hospitalization and death rates by 75%. by Peter Sullivan - 12/14/20 9:40 AM ET. The FDA is reportedly preparing to authorize the Pfizer/BioNTech COVID-19 vaccine in adolescents aged 12 to 15 years following positive trial results in these populations. Several dozen cases have been reported at this time. Two years later, few institutions still have a vaccine requirement in place. Health Officials Nationwide Report Limited Vaccine Supply. The move is an effort to fast-track booster doses amid the emerging threat of variants from South Africa and the United Kingdom. All US adults are now eligible for COVID-19 vaccines, with all 50 states, Washington, DC, and Puerto Rico meeting Bidens April 19 deadline. The European Medicines Agency (EMA) announces that AstraZenecas COVID-19 vaccine is safe after a review of millions of cases concluded it does not increase the overall risk of blood clots. However, employers must still provide accommodations to workers exempt from mandatory immunization under the Americans with Disabilities Act. All available vaccine doses are released, and distribution expands to pharmacies and community health centers. A poll of 962 people with long-term COVID-19 symptoms finds that 39% reported mild to full resolution of their lingering symptoms after they were vaccinated. The society emphasized that both of the 2 mRNA vaccines are safe and release suggestions for optimal timing of the vaccines based on the specific DMT. W ASHINGTON Shipments of Pfizer and BioNTech's newly authorized Covid-19 vaccines should arrive in states on Monday, General Gus Perna, the CEO of Operation Warp Speed, announced Saturday.. Low uptake among this population has experts worried, as poorer individuals tend to face worse health outcomes, including shorter life expectancies. Patients With Blood Cancer Report Vaccine Hesitancy. The president also calls for every state to ensure that teachers, child care providers, and school staff receive at least 1 dose by April. The expanding threat from delta, which Fauci now calls the greatest threat in the US in our attempt to eliminate COVID-19, also now accounts for more than 90% of new COVID-19 cases in the United Kingdom. Vaccine manufacturers have projected that they will supply the United States with as many as 156.2 million to 170 million doses of influenza vaccines for the 2023-2024 season. Amid marked spikes in cases of COVID-19 reported in India, the United States pledged to provide more medical aid to the country, which will include raw materials for vaccine production, test kits, ventilators, and personal protective equipment. Reports of Racial Disparities in Vaccination Rates. Kansas, Louisiana, North Dakota, Ohio, Oklahoma and Texas announce they are expanding vaccine eligibility to all adults, while Minnesota, Indiana, and South Carolina are expected to follow suit later in the week. With supply of COVID-19 vaccines outpacing demand in states such as Louisiana, Kansas, and Mississippi, state officials are turning down shipments from the federal government due to low interest in the shots. Updated data show that the vaccine from Oxford University and AstraZeneca is 76% effective at 3 months after just 1 dose. At this point, the city is in phase 1A of rollout (health care workers, skilled nursing and long-term care facility residents), and phase 1B eligibility (which includes people over age 65) is not slated to open until early February. UK Begins Distributing AstraZeneca/Oxford Vaccine. In comparison, the J&J single-shot vaccine is 66% effective at preventing moderate to severe cases. The news comes as the United States temporarily suspended J&J vaccine shipments as states face a surplus of expiring doses, The Wall Street Journal reports. Although the symptoms were reported to have cleared up in a median of 8 days, physicians should be made aware about the potential adverse effect in order to navigate proper treatment and guidance, according to researchers. US regulators extended the expiration date for the Johnson & Johnson (J&J) COVID-19 vaccine by 6 weeks, preventing millions of already-manufactured doses from being wasted, according to The Associated Press. The CDC's Advisory Committee on Immunization Practices, which makes immunization recommendations for the U.S. population, met on Dec. 11 and will meet again on Dec.13 to iron out the final. After facing scrutiny from the DSMB, the company announces that analyses of more data show the vaccine is 76% effective at preventing symptomatic COVID-19, slightly less than the previously reported 79% efficacy. The percentage of people who say they would rather wait to see how others fared before receiving a vaccine themselves dropped from 31% in January to 22% in February. Rollout has been chaotic, as the CDC relegated responsibility to states to determine vaccination priority and extra doses built up in freezers or were trashed due to regulation confusion. According to a June 2022 study published in The Lancet, COVID-19 vaccination in the United States prevented an additional 1.9 million deaths from December 8, 2020, to December 8, 2021. Appearing on Fox News Sunday, Fauci says that should Trump decide to do so, It would make all the difference in the world., White House to Spend $1.5 Billion on Vaccine Confidence Campaign. Study Shows Patients With Heart Failure Should Be Prioritized for Vaccines. At this time, the vaccine has been administered to 17 million people worldwide with 15 cases of deep vein thrombosis and 22 pulmonary embolisms reportedrates the company says are lower than expected. State and local health officials nationwide are reporting limited vaccine supply, which CDC Director Rochelle Walensky, MD, MPH, said will hopefully be increased after the Biden administrations first 100 days. The Full COVID-19 Vaccine Release Schedule & Plan, Explained Study results, published before publication, show antibodies among those who received the AstraZeneca or Pfizer/BioNTech vaccine were able to neutralize the P1 strain at a rate similar to the B117 variant, first identified in the United Kingdom. Anecdotal evidence indicates that among the 10% to 30% of COVID-19 cases that produce long-lasting symptoms, these symptoms are dissipating in some vaccinated patients. Merck Ends Development of 2 Potential COVID-19 Vaccines. also results in 60,000 to 160,000 hospitalizations and 6,000 to 10,000 deaths annually in Americans over the age of 65. The first new COVID-19 vaccines updated for this fall season are now expected to be available by the end of September, once both the Food and Drug . The first public Covid-19 vaccines reach all states as the US - CNN Incoming CDC Director Walensky to Prioritize Vaccine Rollout. Pfizer/BioNTech Vaccines Efficacy Is Underscored by Real-World Data. Health officials say maintaining public trust is critical because the new respiratory virus vaccines can save lives if widely administered. How New Vaccines Are Developed. Biden announces Mexico will receive 2.5 million doses of the already-produced AstraZeneca vaccine and Canada will receive 1.5 million doses. Both the World Health Organization and United Nations health agencies have urged nations to continue using the vaccine. Using the social vulnerability index, researchers find that in the first 2.5 months of state vaccine rollouts, vaccination coverage was lower in high vulnerability counties nationwide. The Supreme Court announced on Thursday that it would pause a bankruptcy deal for Purdue Pharma that would give billions of dollars to those harmed by the opioid epidemic in . British Study Will Test Mixing AstraZeneca, Pfizer Vaccine Doses. The mumps vaccine Hilleman developed in 1967 from that late-night inspiration is still in use as part of the combination measles, mumps and rubella (MMR) vaccine given to infants the world over. Using epidemiological data from the United Kingdom and estimates of vaccine efficacy to predict the long-term dynamics of the COVID-19 pandemic, researchers find that vaccination alone is insufficient to contain the outbreak. Fauci Advises the United States to Stick With 2-Dose Regimen. The FDA authorizes changes to Modernas vaccine that can provide extra doses from each vial, The Associated Press reports. Current guidelines require 2 doses of the same COVID-19 vaccine, but a British study is testing the safety and efficacy of one shot of the AstraZeneca vaccine followed by a Pfizer dose and vice versa. Part of Smiths responsibility will be to mobilize US resources and bolster vaccine production and distribution across the world. CDC Eases Mask Restrictions for Fully Vaccinated Individuals. Distributing a COVID-19 Vaccine Across the U.S. - KFF Antibodies remain consistent over 3 months and a booster dose at that time increases the efficacy to 82.4%. Access may be further impeded by difficult weather or road conditions. Acting FDA Commissioner Janet Woodcock, MD, notes the expansion is a significant step forward in the nations battle against the pandemic. The 1-shot vaccine by J&J is 72% effective in the United States and 66% effective overall at preventing moderate to severe COVID-19. The findings show a significant increase from 34% overall acceptance in December and 47% in January. The 1-shot vaccine from CanSino Biologics is 66% effective against symptomatic cases and 91% effective against severe cases of COVID-19. A large majority (71%) of the public believes a vaccine will be widely available for anyone who wants it in the U.S. by the summer of 2021. 2020 Many COVID-19 vaccine clinical trials are in process. AstraZeneca Refutes Reports Linking Its Vaccine to Blood Clots. The Biden administration is poised to unveil an expansive public relations campaign aiming to boost confidence in approved COVID-19 vaccines and increase uptake nationwide. US to Share 60M AZ COVID-19 Vaccine Doses With Other Countries. EC Ends Vaccine Contracts With J&J, AstraZeneca. COVID-19 Deaths Most Common in Unvaccinated. Anyone living or working in Alaska who is 16 years or older is now eligible to receive a COVID-19 vaccine, making it the first state to remove eligibility requirements. Getting vaccinated is the best way to help protect people from COVID-19. HHS announces that the CDC plans to provide more than $22 billion in funding for states and territories to support the nations COVID-19 response, as a result of the Coronavirus Response and Relief Supplemental Appropriations Act. (For comparison, flu caused about 171,000 hospitalizations and 16,000 . Production of the companies COVID-19 vaccine is slated to begin within weeks, as the candidates efficacy will be assessed in a trial of over 35,000 adult volunteers in the United States, Asia, Africa and Latin America. The commission also has inquiries into J&J on its delayed vaccine deliveries. News Release March 23, 2021. The first 200 million will be distributed via COVAX in 2021 and the rest will be shared in the first half of 2022. How Long It Took to Develop Other Vaccines in History - Business Insider Results of a phase 2 trial testing Sanofi and GlaxoSmithKlines (GSK)experimental COVID-19 vaccine indicated participants of all ages developed strong levels of neutralizing antibodies similar to those found in people who have recovered from the virus. The FDA announces it will expand its EUA for the Pfizer/BioNTech vaccine to include adolescents aged 12 through 15. Masking is still recommended in crowded outdoor areas such as stadiums where distancing is not possible. Study Validates PSA-Based Recurrence Definitions for Prostate Cancer Prognostication.

Are Elements In The Same Group Similar, Is A 26 Year-old Woman Mature, 1232 White Ave, Kansas City, Mo, Albumentations Randomcrop, Articles W

when was the vaccine released to the public